Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusion
- 15 November 1996
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 78 (10) , 1161-1163
- https://doi.org/10.1016/s0002-9149(96)90072-7
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Analysis of the occurrence and clinical significance of thrombocytopenis with c7E3 (abciximab) in the EPIC trialJournal of the American College of Cardiology, 1996
- Potential value of platelet GPIIb/IIIa antagonist for treating heparin-induced thrombocytopenia (HIT)Journal of the American College of Cardiology, 1996
- 711-3-A Multicenter, Randomized, Double-Blind Pilot Trial of Standard Versus Low Dose Weight-Adjusted Heparin in Patients Treated with the Platelet GP IIb/IIIa Receptor Antibody c7E3 During Percutaneous Coronary RevascularizationJournal of the American College of Cardiology, 1995
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994
- Manipulating the Immune System with Immune GlobulinNew England Journal of Medicine, 1992
- Urgent Treatment of Idiopathic Thrombocytopenic Purpura with Single-Dose Gammaglobulin Infusion Followed by Platelet TransfusionAnnals of Internal Medicine, 1986